Tag: ParathyroidHormone

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Entera Bio Ltd. (NASDAQ: ENTX) Positive Topline EB613 Phase 2 Biomarker Data

financial buzz03/11/2021

1707

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Entera Bio Ltd Announces Positive Topline EB613 Phase 2 Biomarker Data” Entera Bio Ltd (NASDAQ: ENTX) surged over...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Entera Bio Reports Positive Phase 2 Results

Danny Abramov03/11/2021

4113

Entera Bio Ltd. (NASDAQ: ENTX) reported 3 months of results on their ongoing Phase 2 clinical trial of EB613, the company’s orally delivered human parathyroid hormone. Positioned to be...

Tag: ParathyroidHormone

“The Buzz” Show: Entera Bio Ltd. (NASDAQ: ENTX) Positive Topline EB613 Phase 2 Biomarker Data

Entera Bio Reports Positive Phase 2 Results

ABOUT US

Tweets